Kyle Current

Kyle Current

Auto-generated profile, based on publicly available information

Kyle Current

Department of Internal Medicine

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
kranti mapuskarkranti mapuskar
kranti mapuskar
CPCasey F Pulliam
Casey F Pulliam
ATAnn Tomanek‐Chalkley
Ann Tomanek‐Chalkley
JDJason Dierdorff
Jason Dierdorff
KCKyle Current
Kyle Current
BABryan Allen
Bryan Allen
Background: Therapeutic ionizing radiation is a standard treatment modality for thoracic cancers that may affect surrounding normal tissues, including the cardiovascular system. The increasing recognition of mitochondrial health in cellular responses to oxidative stress, particularly in ionizing radiation‐induced cardiac implications, highlights mitochondria as a critical target for therapeutic interventions. Optimizing mitochondrial function to attenuate ionizing radiation‐induced cardiac pathology necessitates balancing killing cancer cells with sparing nonmalignant tissues. Methods: Using a cardiac targeted radiation injury (CTI) model of injury, C57BL/6J female mice were exposed to a single 16 Gy dose and treated with an SOD (superoxide dismutase) mimetic, ucosopasem manganese (RUC) starting 1 hour before CTI, continued daily for 1 week post CTI, and once per week thereafter until euthanasia to investigate cardiopulmonary implications over 9 months. Results: CTI cardiovascular toxicities were observed in all irradiated mice. RUC significantly increased overall survival and alleviated CTI‐induced changes in cardiac function as assessed by cardiac echocardiography. Persistent changes in mitochondrial oxidative phosphorylation proteins and tricarboxylic acid cycle enzymes were notably attenuated following RUC treatment. Interestingly, RUC reduced both CTI‐induced cardiac fibrosis and the activation of the TGF‐β/Smad (transforming growth factor‐beta/suppressor of mothers against decapentaplegic transcription factor family) pathway. Conclusions: This study presents a novel role for selective superoxide dismutase mimetics, such as RUC, in protecting against CTI‐induced cardiovascular toxicities. As RUC dismutates superoxide, the results suggest superoxide plays a key part in the modulation of mitochondrial oxidative phosphorylation, activation of the canonical TGF‐β/Smad pathway, and ionizing radiation cardiovascular side effects. These findings suggest an association between RUC treatment and TGF‐β pathway antagonism that requires additional mechanistic validation.